|
|
|
| home > white papers > Conveying Medical Guidance in Clinical Trials – A Survey - Europital Medical Consultancy |
|
|
 WHITE PAPERS |
|
Europital Medical Consultancy
|
|
Conveying Medical Guidance in Clinical Trials – A Survey
|
|
With the incremental demand for proactive safety surveillance throughout
the conduct of clinical trials, the role of Medical Management is at
the fore in ensuring the safety and wellbeing of the participants. The
complex responsibilities of a Medical Monitor (MM) starts from the
design and development phase, through to study close out. Understanding
the principle behind the protocol and the prospective medical solution
the study would deliver forms the bloodline for the MM role. Often, the
MM is the face of contact for both the site personnel and the study team
members with regard to medical, safety and scientific issues within the
project.
When it comes to medical guidance, the communication channel used to
deliver solutions contributes to a large extent in effectively managing
decisive situations. Our previous study on acquiring medical guidance
from an operations team perspective revealed that e-mails were the most
used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical
guidance delivery, we designed a survey to study the existing trend and
constraints in this communication chain management, as outlined here.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions
Philadelphia, PA & Auburn, AL – September 17, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce its exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-BlisterTM packaging solutions, which help protect and promote speed-to-market for pharmaceutical and medical device products with heightened susceptibility to moisture and gases, especially oxygen.
More info >> |
|
 |
White Papers |
 |
|
The Promise and Challenge of Adaptive Design in Oncology Trials
Medpace
Clinical oncology trials are more complex and time consuming than those
in any other therapeutic area and failure rates are frustratingly high.
Given the urgent need for new oncologic therapies, sponsors are eager to
find more effective ways to conduct clinical research.
Incorporating adaptive design methodologies into clinical trials can
reduce costs and enhance efficiency while maintaining trial integrity.
They can also reduce the number of patients on placebo and
sub-therapeutic doses. In light of this promise, regulatory bodies have
created guidelines supportive of adaptive design.
More info >> |
|
 |
Industry Events |
 |
Partnerships in Clinical Trials Europe 2018
27-29 November 2018, CCIB, Barcelona
Partnerships
in Clinical Trials Europe is back – and bigger than ever.
Europe’s
most complete clinical meeting is bringing together 1000+ of the industry’s
leading experts this November for it’s 17th annual gathering, and
you’re invited!
More info >> |
|
|
|
